These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11463020)

  • 41. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 42. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.
    Lowry DJ; Ryan JD; Ullah N; Kelleher TB; Crowe J
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):32-40. PubMed ID: 21048503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chronic hepatitis C. Treatment of special groups].
    Civeira MP
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():68-70. PubMed ID: 11968348
    [No Abstract]   [Full Text] [Related]  

  • 47. [A French prospective observational study of the treatment of chronic hepatitis C in drug abusers: a commentary].
    Michel L; Roux P; Cohen J; Carrieri MP
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):15-6; author reply 16-7. PubMed ID: 19084361
    [No Abstract]   [Full Text] [Related]  

  • 48. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 49. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Injection drug users can be effectively treated for hepatitis C.
    Stancliff S
    Am Fam Physician; 2011 Mar; 83(6):647; author reply 648. PubMed ID: 21404974
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 52. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 53. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
    Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
    Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatitis C, interferon alpha and psychiatric co-morbidity in intravenous drug users (IVDU) : guidelines for clinical practice.
    De Bie J; Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):68-80. PubMed ID: 15832590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difficulties with interferon treatment in former intravenous drug users.
    Gazdag G; Horváth G; Szabó O; Ungvari GS
    Braz J Infect Dis; 2011; 15(2):163-6. PubMed ID: 21503405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2016 Feb; 164(3):203-4. PubMed ID: 26829915
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Grebely J; Dore GJ; Greenwald R; Swan T; Barua S; Taylor LE
    Ann Intern Med; 2016 Feb; 164(3):203. PubMed ID: 26829914
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
    Remy AJ; Wenger H; Bouchkira H
    Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.